At a Glance
| 2-Aminoindane | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 10–20 mg | 15–30 mg |
| Total Duration | 0.5–1.5 hrs | 3.3–5.7 hrs |
| Routes | oral | insufflatedoral |
2-Aminoindane, a Stimulants, and 2-FMA, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 23 documented effects in common, with 4 effects unique to 2-Aminoindane and 28 unique to 2-FMA. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2-Aminoindane | 2-FMA | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 10–20 mg | 15–30 mg |
| Total Duration | 0.5–1.5 hrs | 3.3–5.7 hrs |
| Routes | oral | insufflatedoral |
| Effects | 27 documented | 51 documented |
| Level | 2-Aminoindane | 2-FMA |
|---|---|---|
| Threshold | 3 mg | 5 mg |
| Light | 5–10 mg | 5–15 mg |
| Common | 10–20 mg | 15–30 mg |
| Strong | 20–40 mg | 30–50 mg |
| Heavy | 40 mg | 50 mg |
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 5–15 mg |
| Common | 15–30 mg |
| Strong | 30–50 mg |
| Heavy | 50 mg |
2-Aminoindane
2-FMA
No direct interaction data available between these substances. This does not mean the combination is safe.